Notice of results - August

London, 23 July 2018 – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK), the multinational generic pharmaceutical company, will announce its interim financial results for the six months ended 30 June 2018 on Wednesday 15 August 2018.

Press Release Corporate 23 July 2018

A presentation and webcast for analysts will be held at 9.30am BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD, with registration and coffee from 9.15am.

To join via conference call please dial:

UK Toll Free Number: 020 3936 2999

US Toll Free Number: 1 855 9796 654

Standard International Access: +44 20 3936 2999

Password: 911652


The results presentation and a webcast recording of the event will be available on the Company's website at or

Playback facility:

A playback of the conference call will be available after the presentation.

United Kingdom - 020 3936 3001

United States - 1 845 709 8569

All other locations - + 44 20 3936 3001

Replay code: 338668


Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.